These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. Orwoll ES; Meier DE J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418 [TBL] [Abstract][Full Text] [Related]
10. Bone histology in patients with nephrotic syndrome and normal renal function. Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454 [TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
12. Calcitropic hormonal status in north Indian patients with end-stage renal disease. Singh AK; Avula S; Kher V; Rao DS; Mithal A Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998 [TBL] [Abstract][Full Text] [Related]
13. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy. Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865 [TBL] [Abstract][Full Text] [Related]
14. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients. Heaf JG; Nielsen LP; Mogensen NB Nephron; 1983; 35(2):103-7. PubMed ID: 6621754 [TBL] [Abstract][Full Text] [Related]
15. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961 [TBL] [Abstract][Full Text] [Related]
16. Mineral and bone metabolism in thyroid disease: a review. Auwerx J; Bouillon R Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957 [TBL] [Abstract][Full Text] [Related]
17. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337 [TBL] [Abstract][Full Text] [Related]
18. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis. de Fremont JF; Sebert JL; Gueris J; Marie P; Coevoet B; Makdassi R; Lambrey G; Meunier P; Fournier A Proc Eur Dial Transplant Assoc; 1979; 16():675-6. PubMed ID: 232918 [No Abstract] [Full Text] [Related]
19. Bone and mineral metabolism and chronic alcohol abuse. Lalor BC; France MW; Powell D; Adams PH; Counihan TB Q J Med; 1986 May; 59(229):497-511. PubMed ID: 3763813 [TBL] [Abstract][Full Text] [Related]